4507.T
Shionogi & Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 2,992.00
+0.34%Price chart
Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
18.4x
EV/EBITDA
10.4x
Market Cap
JPY 2.55T
MomentumView details →
1D Return
+0.34%
YTD Return
+2.39%
RSI (14)
51.1
ValuationView details →
P/E (Fwd)
18.4x
EV/EBITDA
10.4x
Market Cap
JPY 2.55T
RSI (14)
51.1
MomentumView details →
1D Return
+0.34%
YTD Return
+2.39%
Similar companies
Latest newsMore news →
Shionogi plans to start a clinical trial in 2027 for its RS virus treatment drug targeting infants under two years old.2d agoShionogi announced on August 28 that it received an order from the U.S. government for the antibacterial drug cefiderocol, with payment of $36.9 million (about 5.9 billion yen), under a contract signed in April with BARDA.7d agoShionogi & Co is actively pursuing at least three M&A deals.31d ago